These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 3818014)

  • 1. Sex difference in the development of deoxycorticosterone-salt hypertension in the rat.
    Ouchi Y; Share L; Crofton JT; Iitake K; Brooks DP
    Hypertension; 1987 Feb; 9(2):172-7. PubMed ID: 3818014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of vasopressin in the development and maintenance of DOC-salt hypertension in the rat.
    Crofton JT; Share L; Shade RE; Lee-Kwon WJ; Manning M; Sawyer WH
    Hypertension; 1979; 1(1):31-8. PubMed ID: 544512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pressor responsiveness to vasopressin in the rat with DOC-salt hypertension.
    Crofton JT; Share L; Wang BC; Shade RE
    Hypertension; 1980; 2(4):424-31. PubMed ID: 7399626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex difference in pressor responsiveness to vasopressin and baroreflex function in DOC-salt hypertensive rats.
    Ouchi Y; Share L; Crofton JT; Iitake K; Brooks DP
    J Hypertens; 1988 May; 6(5):381-7. PubMed ID: 3385203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osmotic stimulation in DOC-salt hypertension: vasopressin and blood pressure.
    Crofton JT; Share L; Brooks DP
    J Hypertens; 1986 Jun; 4(3):307-12. PubMed ID: 3734447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasopressin: sexual dimorphism in secretion, cardiovascular actions and hypertension.
    Share L; Crofton JT; Ouchi Y
    Am J Med Sci; 1988 Apr; 295(4):314-9. PubMed ID: 3364463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemorrhage in DOC-salt hypertensive rats: plasma and platelet vasopressin.
    Crofton JT; Share L; Brooks DP
    Am J Physiol; 1985 Dec; 249(6 Pt 2):R726-31. PubMed ID: 4073293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gonadectomy abolishes the sexual dimorphism in DOC-salt hypertension in the rat.
    Crofton JT; Share L; Brooks DP
    Clin Exp Hypertens A; 1989; 11(7):1249-61. PubMed ID: 2805361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of extracellular volume expansion in the development of DOC-salt hypertension in the rat.
    Villamil MF; Amorena C; Ponce-Hornos J; Müller A; Taquini AC
    Hypertension; 1982; 4(5):620-4. PubMed ID: 7106934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of brain angiotensin II and C-type natriuretic peptide in deoxycorticosterone acetate-salt hypertension in rats.
    Nishimura M; Ohtsuka K; Sakamoto M; Nanbu A; Takahashi H; Yoshimura M
    J Hypertens; 1998 Aug; 16(8):1175-85. PubMed ID: 9794722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma kinin concentration in deoxycorticosterone-salt hypertension.
    Nakagawa M; Nasjletti A
    Hypertension; 1988 May; 11(5):411-5. PubMed ID: 3284820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcitonin gene-related peptide is a depressor of deoxycorticosterone-salt hypertension in the rat.
    Supowit SC; Zhao H; Hallman DM; DiPette DJ
    Hypertension; 1997 Apr; 29(4):945-50. PubMed ID: 9095081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of vasopressin to the maintenance of blood pressure in deoxycorticosterone-salt induced malignant hypertension in spontaneously hypertensive rats.
    Hiwatari M; Abrahams JM; Saito T; Johnston CI
    Clin Sci (Lond); 1986 Feb; 70(2):191-8. PubMed ID: 3956109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute interaction of vasopressin and neurogenic mechanisms in DOC-salt hypertension.
    Matsuguchi H; Schmid PG
    Am J Physiol; 1982 Jan; 242(1):H37-43. PubMed ID: 7058911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine control of salt and water excretion: the role of vasopressin in DOCA-salt hypertension.
    Hofbauer KG; Mah SC; Baum HP; Hänni H; Wood JM; Kraetz J
    J Cardiovasc Pharmacol; 1984; 6 Suppl 1():S184-91. PubMed ID: 6204139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pressor response to vasopressin and norepinephrine in DOC-salt hypertensive and prehypertensive rats.
    Ouchi Y; Yazaki Y; Tsai RC; Ashida T
    Tohoku J Exp Med; 1988 Feb; 154(2):125-33. PubMed ID: 3381222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central mechanisms in DOC-salt hypertensive rats.
    Matsuguchi H; Sharabi FM; O'Connor G; Mark AL; Schmid PG
    Clin Exp Hypertens A; 1982; 4(8):1303-21. PubMed ID: 7116668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contributions of vasopressin and other pressor systems to DOC-salt hypertension in rats.
    Mento PF; Wang HH; Sawyer WH
    Proc Soc Exp Biol Med; 1984 Jan; 175(1):58-63. PubMed ID: 6694969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deoxycorticosterone hypertension in the intact weanling rat without salt loading.
    Rodriguez-Sargent C; Torres-Negron I; Cangiano JL; Martinez-Maldonado M
    Hypertension; 1990 Feb; 15(2 Suppl):I112-6. PubMed ID: 2298466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of an intracerebroventricularly administered vasopressin V1 antagonist on blood pressure and heart rate in deoxycorticosterone-salt hypertensive rats.
    Toba K; Ouchi Y; Liang J; Akishita M; Orimo H
    J Auton Nerv Syst; 1994 Dec; 50(2):123-9. PubMed ID: 7884152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.